Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.
Journal: The New England journal of medicine
Published: May 29, 2026
Plain language summary of the management of certain side effects of teclistamab in people with multiple myeloma.
Journal: Future oncology (London, England)
Published: January 23, 2026
Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma.
Journal: The New England journal of medicine
Published: December 09, 2025
Revised Recommendations for Restarting Teclistamab Following Dose Delays: Insights from the MajesTEC-1 Study on Clinical Safety, and from Simulated Pharmacokinetics and Cytokine Dynamics.
Journal: Targeted oncology
Published: September 26, 2025
Erratum: Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 26, 2025
Treatment of T-cell Leukemia/Lymphoma in Children and Young Adults With the Memorial Sloan Kettering Cancer Center New York IIB Protocol.
Journal: Journal of pediatric hematology/oncology
Published: March 15, 2024
Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 17, 2023
Comparative Effectiveness of Teclistamab Versus Real-World Physician's Choice of Therapy in LocoMMotion and MoMMent in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Journal: Advances in therapy
Published: October 06, 2023
Nursing Considerations for Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma: Experience with Teclistamab from the MajesTEC-1 Study.
Journal: Seminars in oncology nursing
Published: October 06, 2023
Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation.
Journal: Blood advances
Published: September 11, 2023
Last Updated: 09/26/2026